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Summary An increasing body of evidence indicates that glutathione S-transferases play a role in the intrinsic
and acquired resistance of tumours to anticancer drugs. In view of the wide use of tumour cell lines to
understand the factors which confer either sensitivity or resistance to chemotherapeutic agents we have
determined glutathione S-transferase (GST) activity and isozyme composition in nine human cell lines. These
data have been compared with the values obtained in solid tumours. In most cases overall GST activity was
higher in the tumours than in the cell lines. This was most pronounced for the breast tumour samples relative
to MCF7 cell line. The pi class GST subunit was present at similar concentration in the cell lines and the
tumours, and in most cases was the most abundant subunit present. The alpha and mu class GST were
expressed in most of the cell lines but at much lower concentration than the pi class subunit. Also
considerable variability particularly in the expression of the mu subunits was observed. This was also the case
for the expression of these subunits in the solid tumour samples. The levels of these GSTs (when expressed) in
the solid tumours was invariably higher than that observed in the cell lines. There are therefore several
similarities but also some significant differences in GST expression in solid tumours and cell lines. Whether
the differences are because expression is lost during the generation of the cell lines or whether it reflects the
individuality of human tumours remains to be clearly established.
The glutathione S-transferases (GST) are a multigene family
of dimeric proteins which play a central role in the
detoxification of electrophilic xenobiotics (Chasseaud, 1979).
In man, cytosolic GSTs have been divided into three major
classes termed alpha (basic), mu (neutral) and pi (acidic)
(Mannervik, 1985; Stockman et al., 1987). Proteins within
these groups have marked differences in their substrate
specificity. There is a growing body of evidence which
indicates that GST play an important role in both carcino-
genesis and drug resistance. For example, certain compounds
which inhibit chemical carcinogenesis are often inducers of
the GST in the target tissue (Benson et al., 1978; Benson &
Barretto, 1985). These proteins are also overexpressed in
preneoplastic lesions (Kitahara et al., 1984; Pickett et al.,
1984; Buchmann et al., 1985) and, in addition, have been
demonstrated to be increased in both normal and tumour
cells exposed to cytotoxic drugs (Adams et al., 1985; Wang
& Tew, 1985; Carmichael et al., 1986; Batist et al., 1986;
Evans et al., 1987; Robson et al., 1987; Wolf et al., 1987a;
Hayes & Wolf, 1988).
It is likely that glutathione S-transferase levels and
isoenzyme composition will play a role in both the intrinsic
and acquired resistance to cancer chemotherapy (McGowan
& Fox, 1986; Wolf et al., 1987b; Buller et al., 1987; Lewis et
al., 1988a). Surprisingly little is known about the GST
isoenzyme content of cell lines and work on solid tumours is
still limited. In most cases emphasis has been placed on the
expression of the pi class GST but it is essential that other
GSTs, whose role in drug detoxification is better defined, are
also considered, as GSTs from these groups have also been
shown to be overexpressed in cells made resistant to
cytotoxic drugs (Robson et al., 1987; Lewis et al., 1988b).
In view of the general use of cell lines as models for solid
tumours and for the study of drug resistance GST activity
and isoenzyme profiles from a series of nine human tumour
cell lines have been established and compared to the GST
profiles detected in solid tumours from the same tissue type.
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Materials and methods
All chemicals were purchased from commercial sources and
were of the highest purity available.
Cell culture conditions
The following cell lines: human breast carcinoma MCF7;
ovarian adenocarcinoma PEO4; bladder carcinoma EJ; lung
carcinoma NCI-H322 and NCI-H358; colonic carcinoma
HT29; and lung fibroblast EF484, were grown in RP-I 1640.
The LS174T, a human colonic carcinoma line, was grown in
MEM containing non-essential amino acids. The human
hepatoma line, HepG2, was grown in DMEM medium and
the mouse hepatoma line Hepa I in Ham's F12. All the cell
cultures were supplemented with 10% fetal calf serum (v/v),
streptomycin (100 pgm-1) and penicillin (100 IU m-1). Cells
were grown at 37°C, 100% humidity and 5% CO2 and were
routinely tested for mycoplasma.
Cell preparation
Cells were harvested from confluent cultures, using 0.01%
w/v trypsin, and 0.001% w/v EDTA, washed three times in
phosphate buffered saline (PBS) (140mM NaCl, 2.7 mM KCI,
8mM Na2HPO4, 1.5 mM KH2PO4, pH 7.4) and resuspended
in 400 ul of PBS. Viability was assessed by nigrosin dye
exclusion and cell number determined using a haemo-
cytometer. The cell suspension was sonicated using three 5 s
pulses at maximal power with a 5s cooling period at 4°C
between each treatment. The sonicate was spun at 18,000g
for 20min, the supernatant decanted and stored at -70°C
until required.
Tumour supernatant fractions
Solid tumour samples from human lung, ovary, colon,
bladder, breast and liver carcinomas were frozen in liquid
nitrogen shortly after removal from the patient and stored at
-70°C. All samples were stable under these conditions.
Specimens were scissor-minced and homogenised at a ratio
of 1 g in three volumes of ice-cold 1OmM potassium
phosphate buffer at pH 7.7, containing 1.5% KCI (w/v) and
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0.1 mM EDTA. The sample was then centrifuged at 11,000g
for 20min and the resulting supernatant fraction centrifuged
at 200,000g for 1 h. The final supernatant (cytosolic
fraction) was stored at -70°C. Protein estimations were by
the method of Lowry et al. (1975), using bovine serum
albumin as a standard.
Glutathione-S-transferase assay
GST activity was measured in triplicate at 37°C using 1 mM
l-chloro-2,4-dinitrobenzene (CDNB) as substrate (Habig et
al., 1974).
Western blots
These were carried out using a modified version of that
described by Towbin et al. (1979), as previously described
(Lewis et al., 1988b). Cytosolic protein (50pg) was separated
by SDS/PAGE in 12% (w/v) polyacrylamide gels and trans-
ferred to nitrocellulose. Filters were washed for two 10min
periods, in 50mM Tris/HCl, pH7.9, containing 0.05% (v/v)
Tween 20 (TBST), and then blocked for 1 h with TBST
containing 3% low fat dried milk. Following two further
10min washes the sheets of nitrocellulose were incubated for
1 h with a specific GST antibody (diluted 1:500). Filters were
then washed four times at 15 min intervals with TBST and
then incubated for 1 h with anti-rabbit IgG conjugated to
horseradish peroxidase. Following further washing bound
peroxidase was visualised using 4-chloro-1-napthol as
substrate or by autoradiography after labelling with
0.19 MBq 1251 protein A. Glutathione S-transferase
antibodies to the pi class (GST A), alpha class (GSTB1B,)
and mu class (GSTp) were prepared as described previously
(Stockman et al., 1985, 1987; Hayes et al., 1983).
Cytotoxicity assay
The response of two cell lines, with low or high GST
content, MCF7 and HT29, to cytotoxic compounds were
studied using the 3-(4,5-dimethylthiozol-2-yl)2,5-diphenyl-
tetrazolium bromide (Sigma) assay (MTT) (Carmichael et
al., 1987).
Cell lines were grown for this assay in RPMI 1640 as
described above. A plating density of 5 x 103 cells per
microtitre plate well was used. 1-Chloro-2,4-dinitrobenzene,
ethacrynic acid (Sowa) and chlorambucil (Sigma) were
dissolved in dimethylsulphoxide (DMSO) (Sigma)
immediately before use and diluted in serum-free medium.
The cells were then grown in the presence of varying drug
concentrations for 5 days. Cell number was then determined
by measuring formazan dye formation using MTT and
reading the subsequent colour at 540 nm (Carmichael et al.,
1987).
Results
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Figure 1 Glutathione S-transferase activity in tumour cell lines.
Cells (107) were harvested and prepared as described in the
Materials and methods section. GST activity was measured at
37°C using CDNB as a substrate (23) and is expressed in nmol
conjugate formed min- mg protein- . Values shown are means
from three separate determinations. Less than 10% variation
between values from a particular sample was observed. The
source of the cell line is indicated above the values. The cell lines
were: P=PEO4, L=LS174T, HT=29, EJ=EJ, M=MCF7,
HEP =HEPG2, H =HEPAI, E =EF484, H2 =NCI H322 and
H5=NCI H358.
had a molecular weight which was too high to be this
subunit and is assumed to be due to a non-specific reaction,
In the majority of samples the pi class subunit was by far the
most abundant GST, being at least 10-fold higher than the
alpha and mu class enzymes and in most cases would appear
to be responsible for the majority of the CDNB activity. All
the cell lines contained proteins which reacted with the alpha
class(B1BI) GST antibody. The level of this protein was low
with the exception of the human hepatoma line HepG2
where it represented the major GST. Both hepatoma cell
lines also expressed the mu class proteins, the Hepa I line
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GST activity towards CDNB in nine cell lines derived from
a variety of human tumours and the mouse hepatoma cell
line, Hepa I, is shown in Figure 1. Significant variation in
activity between the lines was observed. This was particularly
the case for the breast cancer cell line, MCF7 which had by
far the lowest activity (3.5 nmol conjugate formed min-I mg
protein-') and was approximately 60-fold lower than the
ovarian adenocarcinoma cell line PEO4 (210.3 nmol CDNB
conjugated min- mg protein-1). This difference in GST
activity was also reflected in the glutathione S-transferase
isoenzyme content.
The pi class glutathione S-transferase (GST A) was
expressed in most of the cell lines (Figure 2). The level of
expression appeared to fall into two distinct groups: cell lines
with high levels of this subunit (i.e.- PEO4, EF484, EJ,
NCI H322, NCI H358, LS 174T) and those with very low or
undetectable levels (i.e. MCF7, Hepa I and HepG2). The
band detected using the pi antibody in the HepG2 sample
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Figure 2 Glutathione transferase isoenzyme content in tumour
cell lines. Cells (107) were harvested and supernatant fractions
prepared as described in the Materials and methods section.
Supernatant proteins were separated by SDS/PAGE, transferred
to nitrocellulose and probed with antibodies raised against the
three known human GST isoenzyme classes: pi (A), alpha (B1B1),
and mu (j), as described in the Materials and methods section.
The cell lines were: P=PEO4, M=MCF7, E=EF484, EJ=EJ,
H2 =NCI H322, H5 =NCI H358, H =HEPAI, HEP =HEPG2,
L=LS174T, HT=HT29 and S=standard affinity purified GST.
50pg of protein was taken per track with the exception of the
HT29 sample where 25 pg was used. A =autoradiographs
developed after 24h exposure; B =autoradiographs developed
after 96h exposure. The autoradiograph of the pi blot was
overexposed after 96 h and is therefore not shown. ND =not
determined.
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having the highest levels of this subunit. Although almost all
the cell lines contained the mu class GST considerable
variability in level between the lines was observed. The cross-
reacting band in the HT29 sample was thought not to be a
GST.
In order to assess whether GST activity and isozyme
composition in the cell lines reflected those found in vivo,
mean solid tumour CDNB values were compared to the
activity in the cell lines (Figure 3). In almost all cases the
mean CDNB activity was higher in the tumour than the cell
line but the activities of the cell lines were usually within the
variability observed within the tumour. It should be noted
that because of the small volume of the cell line samples
different methods of preparation of the cell line and tumour
supernatant fractions were employed. This could contribute
to the differences observed. In the ovarian cell line CDNB
Ut
activity was higher than in the solid tumour. The only case
where cell line CDNB activity did not approximate to that
of the solid tumours was the case of the MCF7 cell line (62.7
and 3.5 nmol CDNB conjugated min- mg soluble protein-
I
respectively). Consistent with the lower GST activity
measured in this cell line, however, the breast tumour GST
level was also lower than in the other solid tumours
examined and in some cases was extremely low.
Comparison of GST isoenzyme content with the cell lines
is shown in Figure 4. In certain cases two tumour samples
are shown to demonstrate the extremes of variability in
subunit composition. A normal liver sample is included for
comparison purposes. Consistent with previous reports and
consistent with the findings using the cell lines in many cases
the pi class GST is the most abundant protein found in the
solid tumours. It is, however, important to note that this was
not always the case. The level of this subunit in the MCF7
cell line and the lung NCI H322 cell line was lower than any
of the large number of solid tumour samples of these types
studied. The level of the alpha and mu GST subunits in
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Figure 3 Glutathione S-transferase activity in tumour cell lines
and solid tumour samples. Values were determined as described
in Figure 1. The cell lines used were HT29, HEPG2, MCF7,
NCI H322, PEO4 and EJ for colon, liver, breast, lung, ovary and
bladder tissues respectively. The number of tumour samples
taken for each determination is given in parentheses and
presented as mean+standard deviation. Values are expressed in
nmol CDNB conjugated min- mg protein-'.
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Figure 4 GST isoenzyme content in tumour cell lines and solid
tumours. Western blots were carried out as described in the
Materials and methods section. 25Mg of cytosolic protein was run
per track. C=cell line; T=solid tumour; N=normal tissue. The
cell lines taken were MCF7, HT29, NCI H322, PEO4, EJ and
HepG2 for breast, colon, lung, ovary, bladder and liver
respectively. More than one tumour is shown in certain cases to
demonstrate the extremes observed in GST expression. The
autoradiographs were developed after 24 h exposure so that a
comparison could be made. The sensitivity of the blot was lower
than that shown in Figure 2 in order to avoid overexposure of
some of the bands. The standards (STD) were isolated from
human liver and lung (Hayes et al., 1983; Stockman et al., 1987).
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Figure 5 Sensitivity of the MCF7 or HT29 cell lines to
glutathione S-transferase substrates and chlorambucil. MTT
assays were carried out as described in the Materials and methods
section. The values shown are the mean of triplicate
determinations +s.d.
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human tumours is subject to large individual variation
(Carmichael et al., 1988; Forrester et al., Carmichael et al.,
Harris et al., in preparation) as shown in Figure 4. Of
particular note is that occasionally breast tumours contain
high levels of alpha class GST subunits (not shown) as well
as significant concentrations of mu class enzymes. These
subunits are also consistently observed in all other human
tumour types, and occasionally at levels higher than the pi
class GST. In this regard extremely high levels of the alpha
class subunit in the ovarian tumour are worthy of note, as it
would appear to be the major GST present and was absent
from the normal tissue. However, more samples need to be
tested to see if this is a consistent observation. It is not
known whether the higher molecular weight bands seen with
the alpha class GST antibody in some of the tumour samples
or cell lines are indeed GST. Alpha and mu class GST also
appear to be the major GST in the hepatoma sample
studied. No correlation between the tumour concentration of
the alpha and mu class GST subunits and those found in the
cell lines was observed.
In order to establish whether the cellular GST level may
influence the susceptibility of cells to cytotoxic compounds,
the relative sensitivity of cell lines with high and low GST
content to known GST substrates, as well as chlorambucil
was investigated. The MCF7 cell line with low GST content
was significantly more sensitive to both CDNB and
ethacrynic acid, as well as to the anticancer drug
chlorambucil, than the colon cell line HT29 which had high
GST content (Figure 5).
Discussion
Glutathione S-transferases are directly implicated in the
protection of cells against cytotoxic and carcinogenic
chemicals (Chasseaud, 1979). Although the direct
involvement of these enzymes in the detoxification of anti-
cancer drugs has not been clearly established, the GST-
mediated conjugation of melphalan has been reported (Dulik
et al., 1986). This implies that other nitrogen mustards of
similar structure will also be substrates for these enzymes.
Indeed, it has been demonstrated that cell lines resistant to
nitrogen mustards, such as chlorambucil and cyclo-
phosphamide have elevated GST content (Wang & Tew,
1985; McGowan & Fox, 1986; Robson et al., 1987; Buller et
al., 1987), as have cell lines resistant to other alkylating
agents such as nitrosoureas (Evans et al., 1987). The recent
finding that elevated GST levels are associated with an
amplification of alpha class GST genes (Lewis et al., 1988b)
considerably strengthens the case for a direct role for these
enzymes in the resistance observed.
Cell lines are used extensively for studies into the
mechanism of action of anticancer drugs. We have therefore
tried to establish the GST isozyme composition of a variety
of commonly used cell lines for both mechanistic studies and
also to compare with GST content of tumours derived from
the same tissue type.
This study and those of others show that GST activity and
isozyme composition in tumour tissues derived from the
same histological subtype are subject to considerable
individual varition (Di Ilio et al., 1985, 1988; Carmichael et
al., 1988; Shea et al., 1988; Forrester et al., in preparation).
Apart from liver and possibly the ovary, the acidic pi class
protein was in general the most abundant GST form in all
the human tumours studied, including lung, colon, bladder
and breast (Di Ilio et al., 1985, 1988; Carmichael et al., 1988;
Kodate et al., 1986; Shea et al., 1988) and was also the most
abundant in most of the cell lines, with the notable exception
of the hepatoma cell lines. The presence of other as yet
unidentified GST in some of these samples is possible. A
difference was seen in the level of mu and alpha class
subunits in the tumours relative to the cell lines. However,
these GST subunits are subject to genetic polymorphism and
exhibit a very wide variation in concentration between
tumour samples (Mannervik, 1985; Carmichael et al., 1988;
De Ilio et al., 1988; Forrester et al., in preparation). All GST
isozymes exhibit a different spectrum of activity and it
remains to be established whether these differences in
expression of alpha and mu subunits are important in
determining sensitivity to cytotoxic compounds.
Many factors will determine the sensitivity of tumours and
tumour cell lines to anticancer drugs. It was, however, the
MCF7 cell line with low GST content that was more
susceptible than the human colon HT29 cell line to the toxic
effects of GST substrates. It has recently been shown that
factors which influence GST activity in cells can increase
sensitivity of tumour cell lines towards compounds such as
chlorambucil (Tew et al., 1988). We are currently trying to
establish whether these differences in sensitivity can be
related to GST isozyme content.
In conclusion, it is clear that the pi class GST is the major
isozyme expressed in most of the human tumours studied to
date. It is also the major subunit expressed in most tumour
cell lines (Di Ilio et al., 1985; Carmichael et al., 1988; Shea et
al., 1988; Awasthi et al., 1988). In many tumours this
subunit appears to be subject to small individual variation
(2-3-fold) within any tumour type (Carmichael et al., 1988;
Forrester et al., unpublished). The role of this subunit in the
metabolism of anticancer drugs remains unclear and
represents an important theme for further study.
The alpha and mu class GST show large individual
differences between different tumours and also within a
specific tumour type. This could be due to environmental,
genetic or other factors. It is therefore not surprising that the
tumour content of these subunits could not be correlated
with that of the cell lines. However, in certain tumours the
content of these subunits was high and, in view of their
distinct substrate specificities and the finding that they are
also over-expressed in drug resistant cell lines, should also be
seriously considered in relation to intrinsic and acquired
drug resistance.
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